Name | Niraparib metabolite M1 |
---|---|
Synonyms |
2-{4-[(3S)-3-Piperidinyl]phenyl}-2H-indazole-7-carboxylic acid
2H-Indazole-7-carboxylic acid, 2-[4-[(3S)-3-piperidinyl]phenyl]- |
Description | Niraparib metabolite M1 is a metabolite of niraparib, and the latter one acts as a novel poly(ADP-Ribose) polymerase (PARP) inhibitor. |
---|---|
Related Catalog | |
In Vitro | Niraparib metabolite M1 has the validation in plasma and urine for the support of clinical studies such as the mass balance study and the absolute bioavailability study[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 442.0±45.0 °C at 760 mmHg |
Molecular Formula | C19H19N3O2 |
Molecular Weight | 321.373 |
Flash Point | 221.1±28.7 °C |
Exact Mass | 321.147736 |
LogP | 4.01 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.693 |
Storage condition | 2-8℃ |